journal article·2021-11Open access

Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells

Xuemei Yao, Wei Li, De Fang, Chuyu Xiao, Xiao Wu, Menghuan Li, Zhong Luo

Advanced Science· Volume 8· Issue 22

Abstract

Abstract Ferroptosis is a new form of regulated cell death, which is characterized by the iron‐dependent accumulation of lethal lipid peroxides and involved in many critical diseases. Recent reports revealed that cellular energy metabolism activities such as glycolysis, pentose phosphate pathway (PPP), and tricarboxylic acid cycle are involved in the regulation of key ferroptosis markers such as reduced nicotinamide adenine dinucleotide phosphate (NADPH), glutathione (GSH), and reactive oxygen species (ROS), therefore imposing potential regulatory roles in ferroptosis. Remarkably, tumor cells can activate adaptive metabolic responses to inhibit ferroptosis for self‐preservation such as the upregulation of glycolysis and PPP. Due to the rapid proliferation of tumor cells and the intensified metabolic rate, tumor energy metabolism has become a target for disrupting the redox homeostasis and induce ferroptosis. Based on these emerging insights, regulatory impact of those‐tumor specific metabolic aberrations is systematically characterized, such as rewired glucose metabolism and metabolic compensation through glutamine utilization on ferroptosis and analyzed the underlying molecular mechanisms. Additionally, those ferroptosis‐based therapeutic strategies are also discussed by exploiting those metabolic vulnerabilities, which may open up new avenues for tumor treatment in a clinical context.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ferroptosis and cancer prognosis · Cancer, Lipids, and Metabolism · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Life Science Chongqing University Chongqing 400044 China

Breast Cancer Center Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment Chongqing University Cancer Hospital Chongqing 400044 P. R. China

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities · Chongqing Science and Technology Commission · Key Technologies Research and Development Program

References (100+)

Show source-provided references
1. 10.3322/caac.2149210.3322/caac.21492 ↗
2. 10.1038/s41568-019-0110-310.1038/s41568-019-0110-3 ↗
3. 10.1016/S1470-2045(18)30761-710.1016/S1470-2045(18)30761-7 ↗
4. 10.3322/caac.2159010.3322/caac.21590 ↗
5. 10.1038/s41571-020-0341-y10.1038/s41571-020-0341-y ↗
6. 10.1016/j.drup.2009.08.00110.1016/j.drup.2009.08.001 ↗
7. 10.1016/j.celrep.2020.10773110.1016/j.celrep.2020.107731 ↗
8. 10.1038/nrclinonc.2017.16610.1038/nrclinonc.2017.166 ↗
9. 10.1038/s41573-019-0044-110.1038/s41573-019-0044-1 ↗
10. 10.1038/nature2429710.1038/nature24297 ↗
11. 10.1016/S1535-6108(03)00050-310.1016/S1535-6108(03)00050-3 ↗
12. 10.1016/j.chembiol.2008.02.01010.1016/j.chembiol.2008.02.010 ↗
13. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
14. 10.1182/blood.201900290710.1182/blood.2019002907 ↗
15. 10.1161/CIRCRESAHA.120.31650910.1161/CIRCRESAHA.120.316509 ↗
16. 10.1002/ijc.2815910.1002/ijc.28159 ↗
17. 10.7554/eLife.0252310.7554/eLife.02523 ↗
18. 10.3390/cancers1204082710.3390/cancers12040827 ↗
19. 10.1016/j.molcel.2018.10.04210.1016/j.molcel.2018.10.042 ↗
20. 10.1038/s41586-019-1707-010.1038/s41586-019-1707-0 ↗
21. 10.1038/s41586-019-1705-210.1038/s41586-019-1705-2 ↗
22. 10.1016/j.cmet.2019.12.00710.1016/j.cmet.2019.12.007 ↗
23. 10.1016/j.cell.2013.12.01010.1016/j.cell.2013.12.010 ↗
24. 10.1101/gad.334219.11910.1101/gad.334219.119 ↗
25. 10.1101/gad.314674.11810.1101/gad.314674.118 ↗
26. 10.1126/science.aaw987210.1126/science.aaw9872 ↗
27. 10.1016/j.redox.2020.10180710.1016/j.redox.2020.101807 ↗
28. 10.1126/science.123.3191.30910.1126/science.123.3191.309 ↗
29. 10.1016/j.semcancer.2014.01.00710.1016/j.semcancer.2014.01.007 ↗
30. 10.1038/nrurol.2010.4710.1038/nrurol.2010.47 ↗
31. 10.1038/s41580-019-0185-410.1038/s41580-019-0185-4 ↗
32. 10.1126/science.116080910.1126/science.1160809 ↗
33. 10.1016/j.tcb.2008.01.00610.1016/j.tcb.2008.01.006 ↗
34. 10.1038/s41556-019-0299-010.1038/s41556-019-0299-0 ↗
35. 10.1158/0008-5472.CAN-18-254510.1158/0008-5472.CAN-18-2545 ↗
36. 10.1158/0008-5472.CAN-03-110110.1158/0008-5472.CAN-03-1101 ↗
37. 10.1038/s41556-020-0461-810.1038/s41556-020-0461-8 ↗
38. 10.1038/s41467-019-13601-810.1038/s41467-019-13601-8 ↗
39. 10.1038/s41422-020-0372-z10.1038/s41422-020-0372-z ↗
40. Sonveaux P. · J. Clin. Invest. · 2008 · 118 · 3930
41. 10.1038/nrclinonc.2016.6010.1038/nrclinonc.2016.60 ↗
42. 10.1210/er.2017-0006410.1210/er.2017-00064 ↗
43. 10.1038/s41467-019-08921-810.1038/s41467-019-08921-8 ↗
44. 10.1161/CIRCRESAHA.115.30623310.1161/CIRCRESAHA.115.306233 ↗
45. 10.1016/j.cell.2017.09.02110.1016/j.cell.2017.09.021 ↗
46. 10.1016/j.molcel.2016.02.01110.1016/j.molcel.2016.02.011 ↗
47. 10.1158/1078-0432.CCR-17-307010.1158/1078-0432.CCR-17-3070 ↗
48. 10.1016/j.cmet.2016.07.00310.1016/j.cmet.2016.07.003 ↗
49. 10.1161/CIRCRESAHA.116.30932610.1161/CIRCRESAHA.116.309326 ↗
50. 10.1161/CIRCRESAHA.114.30055910.1161/CIRCRESAHA.114.300559 ↗
51. 10.1038/nrm225610.1038/nrm2256 ↗
52. 10.1016/j.semcancer.2017.04.00510.1016/j.semcancer.2017.04.005 ↗
53. 10.1182/blood-2013-04-49194410.1182/blood-2013-04-491944 ↗
54. 10.1161/CIRCRESAHA.118.31270810.1161/CIRCRESAHA.118.312708 ↗
55. 10.1016/j.molcel.2015.06.01110.1016/j.molcel.2015.06.011 ↗
56. 10.1016/j.redox.2019.10141810.1016/j.redox.2019.101418 ↗
57. 10.1016/j.mam.2010.03.00210.1016/j.mam.2010.03.002 ↗
58. 10.1126/science.aav401110.1126/science.aav4011 ↗
59. 10.2147/OTT.S25499510.2147/OTT.S254995 ↗
60. 10.1038/s41467-020-14324-x10.1038/s41467-020-14324-x ↗
61. 10.1038/nature0585910.1038/nature05859 ↗
62. 10.1007/s13238-017-0451-110.1007/s13238-017-0451-1 ↗
63. 10.1016/j.molmed.2012.05.00410.1016/j.molmed.2012.05.004 ↗
64. 10.1073/pnas.96.6.304710.1073/pnas.96.6.3047 ↗
65. 10.1158/0008-5472.CAN-15-010810.1158/0008-5472.CAN-15-0108 ↗
66. 10.1158/0008-5472.CAN-14-226010.1158/0008-5472.CAN-14-2260 ↗
67. 10.1016/j.bbrc.2019.08.09610.1016/j.bbrc.2019.08.096 ↗
68. 10.1177/247255521773155610.1177/2472555217731556 ↗
69. 10.1111/brv.1214010.1111/brv.12140 ↗
70. 10.1038/ncb217210.1038/ncb2172 ↗
71. 10.1016/j.cell.2018.02.04810.1016/j.cell.2018.02.048 ↗
72. 10.1016/j.redox.2020.10168810.1016/j.redox.2020.101688 ↗
73. 10.1016/j.molcel.2016.04.00910.1016/j.molcel.2016.04.009 ↗
74. 10.1038/ncb325510.1038/ncb3255 ↗
75. 10.1016/j.molcel.2020.11.02410.1016/j.molcel.2020.11.024 ↗
76. 10.1038/s41589-020-0472-610.1038/s41589-020-0472-6 ↗
77. 10.1038/nchembio.223910.1038/nchembio.2239 ↗
78. 10.1016/j.devcel.2020.06.01910.1016/j.devcel.2020.06.019 ↗
79. 10.1073/pnas.200682811710.1073/pnas.2006828117 ↗
80. 10.1515/BC.2009.03310.1515/BC.2009.033 ↗
81. 10.1016/j.mam.2008.08.00610.1016/j.mam.2008.08.006 ↗
82. 10.1038/s41556-020-0496-x10.1038/s41556-020-0496-x ↗
83. Liu X. · Genes Dis. · 2020 · 40 · 3533
84. 10.3390/antiox912125710.3390/antiox9121257 ↗
85. 10.1073/pnas.05145439810.1073/pnas.051454398 ↗
86. 10.1038/s41557-019-0261-610.1038/s41557-019-0261-6 ↗
87. 10.1038/s41589-020-0613-y10.1038/s41589-020-0613-y ↗
88. 10.1038/nchembio.207910.1038/nchembio.2079 ↗
89. 10.1016/j.chembiol.2015.11.01610.1016/j.chembiol.2015.11.016 ↗
90. 10.1073/pnas.200994311710.1073/pnas.2009943117 ↗
91. 10.1016/j.redox.2019.10115410.1016/j.redox.2019.101154 ↗
92. 10.1016/j.cmet.2017.10.00910.1016/j.cmet.2017.10.009 ↗
93. 10.1007/s00018-019-03351-710.1007/s00018-019-03351-7 ↗
94. 10.1016/j.molcel.2017.05.03210.1016/j.molcel.2017.05.032 ↗
95. 10.1038/nature1106610.1038/nature11066 ↗
96. 10.1080/23723556.2020.176124210.1080/23723556.2020.1761242 ↗
97. 10.1016/j.cmet.2017.07.00910.1016/j.cmet.2017.07.009 ↗
98. 10.1038/s41392-020-00297-210.1038/s41392-020-00297-2 ↗
99. 10.1016/j.cellsig.2010.05.02410.1016/j.cellsig.2010.05.024 ↗
100. 10.7554/eLife.3615810.7554/eLife.36158 ↗